A detailed history of Covestor LTD transactions in Arvinas, Inc. stock. As of the latest transaction made, Covestor LTD holds 3 shares of ARVN stock, worth $73. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 4 25.0%
Holding current value
$73
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$23.66 - $32.73 $23 - $32
-1 Reduced 25.0%
3 $0
Q1 2024

May 10, 2024

SELL
$36.38 - $52.31 $36 - $52
-1 Reduced 20.0%
4 $0
Q3 2023

Nov 13, 2023

BUY
$19.64 - $28.21 $19 - $28
1 Added 25.0%
5 $0
Q4 2022

Feb 13, 2023

SELL
$32.47 - $57.24 $32 - $57
-1 Reduced 20.0%
4 $0
Q2 2022

Aug 10, 2022

SELL
$36.01 - $74.24 $72 - $148
-2 Reduced 28.57%
5 $0
Q1 2022

May 13, 2022

SELL
$60.27 - $81.57 $120 - $163
-2 Reduced 22.22%
7 $1,000
Q4 2021

Feb 10, 2022

BUY
$65.85 - $96.21 $592 - $865
9 New
9 $1,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.3B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.